awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34088424-63306E9A-B474-4C55-8C57-EF8FD9302436
Q34088424-63306E9A-B474-4C55-8C57-EF8FD9302436
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34088424-63306E9A-B474-4C55-8C57-EF8FD9302436
Understanding resistance to EGFR inhibitors-impact on future treatment strategies
P2860
Q34088424-63306E9A-B474-4C55-8C57-EF8FD9302436
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34088424-63306E9A-B474-4C55-8C57-EF8FD9302436
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e6ac8fc8d67ada6a8ac0e23b915759acd3bf3ea
P2860
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.